Home » Topics » Regulatory

Regulatory
RSS

FDA clears potent pain reliever without opioid side effects from Wyeth-Ayerst

July 24, 1997

Teva's generic antihypertensive combination tentatively approved

July 23, 1997

U.K. approves Astra's treatment for ulcerative colitis

July 23, 1997

Prograf to be submitted in Japan for atopic dermatitis

July 22, 1997

TAP receives FDA approval to market new formulation of Lupron Depot

July 21, 1997

Rogaine Extra Strength for Men recommended for approval as OTC

July 21, 1997

FDA clears new indication and new labeling for Zoloft

July 18, 1997

Ganciclovir implant effective in treating CMV retinitis

July 17, 1997

RPR launches room-temperature formulation of DDAVP

July 16, 1997

Athena Neurosciences and Wyeth-Ayerst copromote Naprelan

July 16, 1997